Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 18;29(7):2382-2393.
doi: 10.1021/acs.bioconjchem.8b00317. Epub 2018 Jun 15.

Synthesis of Azide-Modified Chondroitin Sulfate Precursors: Substrates for "Click"- Conjugation with Fluorescent Labels and Oligonucleotides

Affiliations

Synthesis of Azide-Modified Chondroitin Sulfate Precursors: Substrates for "Click"- Conjugation with Fluorescent Labels and Oligonucleotides

Satish Jadhav et al. Bioconjug Chem. .

Abstract

Azidopropyl-modified precursors of chondroitin sulfate (CS) tetrasaccharides have been synthesized, which, after facile conversion to final CS structures, may be conjugated with alkyne-modified target compounds by a one-pot "click"-ligation. RP HPLC was used for the monitoring of the key reaction steps (protecting group manipulation and sulfation) and purification of the CS precursors (as partially protected form, bearing the O-Lev, O-benzoyl, and N-trichloroacetyl groups and methyl esters). Subsequent treatments with aqueous NaOH, concentrated ammonia, and acetic anhydride (i.e., global deprotection and acetylation of the galactosamine units) converted the precursors to final CS structures. The azidopropyl group was exposed to a strain-promoted azide-alkyne cycloaddition (SPAAC) with a dibenzylcyclooctyne-modified carboxyrhodamine dye to give labeled CSs. Conjugation with a 5'-cyclooctyne-modified oligonucleotide was additionally carried out to show the applicability of the precursors for the synthesis of biomolecular hybrids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Synthesis of Glycosyl Acceptor 7
Reagents and conditions: (i) hydrazine acetate, DMF; (ii) TBDMSCl, imidazole, DMF, room temperature; (iii) 0.1 mol L–1 NaOMe in MeOH, room temperature; (iv) PhCH(OMe)2, p-TSA, acetonitrile, room temperature; (v) levulinic acid, DCC, DMAP, CH2Cl2, room temperature; (vi) Et3N·3HF, THF, room temperature; (vii) CCl3CN, DBU, CH2Cl2, 0°C; (viii) 3-azidopropan-1-ol, TMSOTf, CH2Cl2, −30°C; (ix) hydrazine acetate, pyridine, room temperature.
Scheme 2
Scheme 2. Synthesis of Glycosyl Acceptor 10 and Glycosyl Donor 12
Reagents and conditions: (i) TMSOTf, CH2Cl2, 0°C; (ii) hydrazine acetate, pyridine, room temperature; (iii) Et3N·3HF, THF, room temperature; (iv) CCl3CN, DBU, CH2Cl2, 0°C.
Scheme 3
Scheme 3. Synthesis of Chondroitin Sulfate Precursors 13 and 15
Reagents and conditions: (i) TMSOTf, CH2Cl2, −30°C.
Scheme 4
Scheme 4. Synthesis of Chondroitin Sulfate Precursors (18–23) and RP HPLC Monitoring of the Reactions
Reagents and conditions: (i) thiourea, pyridine–EtOH (1:1, v/v), 2 h at 80°C; (ii) SO3·TMA, DMF, overnight at 50°C; (iii) 0.1% aq TFA, 5 h at r.t.; (iv) Ac2O, pyridine, overnight at r.t.; (v) 80% aq AcOH, 1 h at 100°C. RP HPLC conditions: an analytical RP HPLC column (250 × 4.6 mm, 5 μm), flow rate: 1.0 mL min–1, detection at 220 nm, profiles a, d, and g: a gradient elution from 20 to 100% MeCN in 0.1 mol L–1 aqueous triethylammonium acetate (0–25 min), profiles b, c, e, f, and h: a gradient elution from 0 to 50% MeCN in 0.1 mol L–1 aqueous triethylammonium acetate (0–25 min), then from 50% to 100% MeCN in 0.1 mol L–1 aqueous triethylammonium acetate (25–30 min), profiles of crude product (16–23) mixtures described.
Scheme 5
Scheme 5. Synthesis of Carboxyrhodamine-Labeled CSs (2426, 29, 30)
Reagents and conditions: (i) 0.1 mol L–1 aq NaOH, 3 h at 55°C; (ii) conc. aq NH3, 4 days at 55°C; (iii) Ac2O, Et3N, aq MeCN; (iv) conc. aq NH3, 5 h at 55°C; (v) dibenzylcyclooctyne-PEG4-5/6-carboxyrhodamine (2 equiv), DMF, overnight at room temperature; (vi) 80% aq AcOH, 1 h at 100°C; (vii) SO3·TMA, DMF, overnight at 50°C. RP HPLC conditions: an analytical RP HPLC column (250 × 4.6 mm, 5 μm), flow rate: 1.0 mL min–1, detection at 501 nm, a gradient elution from 0 to 100% MeCN in 0.1 mol L–1 aqueous triethyammonium acetate over 30 min. Notes: (a) An RP HPLC profile of the crude product (24) mixture; (b–f) RP HPLC profiles of the purified products (2426, 29, 30). Retention times (tr) of the product peaks: 24: 18.8 min, 25: 19.3 min, 26: 19.4 min, 29: 22.0 min, 30: 21.8 min.
Scheme 6
Scheme 6. Synthesis of CS–Oligonucleotide Conjugates (3234)
Reagents and conditions: (i) 0.1 mol L–1 aq NaOH, 3 h at 55°C; (ii) conc. aq NH3, 4 days at 55°C; (iii) Ac2O, Et3N, aq MeCN; (iv) conc. aq NH3, 5 h at 55°C; (v) 5′-cyclooctyne-modified 2′-deoxy oligoribonucleotide 31 (1.5 equiv), H2O, overnight at 55°C.; RP HPLC conditions: an analytical RP HPLC column (250 × 4.6 mm, 5 μm), flow rate: 1.0 mL min–1, detection at 260 nm, a gradient elution from 0 to 70% MeCN in 0.1 mol L–1 aqueous triethylammonium acetate over 30 min. An RP HPLC profile of the crude (a–c) and homogenized (d–f) products (32: tr = 13.4 min, 33: tr = 13.0 min, 34: tr = 13.2 min).
Figure 1
Figure 1
Labeled CSs (29 and 30) images. Cultured hippocampal neurons from rat brain at 7 days in vitro were treated with CS conjugates (29 or 30) at 50 or 10 nM unconjugated dye (DBCO-PEG4–5/6-Carboxyrhodamine 110) or with DMSO for 10 days as indicated. Cells were fixed with 4% cold paraformaldehyde in phosphate buffered saline and stained with Hoechst-33342. Confocal images of Z-sections through nuclei are shown. Signal for the conjugates or the dye is shown in green while nuclei are highlighted in blue. Scale = 10 μm.

References

    1. Lauder R. (2009) Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. Complement. Ther. Med. 17, 56–62. 10.1016/j.ctim.2008.08.004. - DOI - PubMed
    1. Galtrey C. M.; Fawcett J. W. (2007) The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 54, 1–18. 10.1016/j.brainresrev.2006.09.006. - DOI - PubMed
    1. Murrey H. E.; Hsieh-Wilson L. C. (2008) The Chemical Neurobiology of Carbohydrates. Chem. Rev. 108, 1708–1731. 10.1021/cr078215f. - DOI - PMC - PubMed
    1. Ichijo H.; Sugiura N.; Kimata K. (2013) Application of Chondroitin Sulfate Derivatives for Understanding Axonal Guidance in the Nervous System during Development. Polymers 5, 254–268. 10.3390/polym5010254. - DOI
    1. Swarup V. P.; Mencio C. P.; Hlady V.; Kuberan B. (2013) Sugar Glues for Broken Neurons. Biomol. Concepts 4 (3), 233–257. 10.1515/bmc-2012-0042. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources